With the analysis among 62 patents, we discovered top 22 key players by total patent application. ChemoCentryx, Inc., Novartis AG, Spero Therapeutics, Inc. are dominant in this area. They take 46.77% of the total patent filing.
California, United States
Patent: 13
Basel-Stadt, Switzerland
Patent: 7
Massachusetts, United States
Patent: 3
Guizhou Sheng, China
Patent: 1
Guangxi Zhuangzu Zizhiqu, China
Patent: 1
Shanghai Shi, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
No data, please try another search term
With the analysis among related 21 patents applied in the last 5 years. We discover 7 most active companies in this area. The fast-growing ChemoCentryx, Inc., Spero Therapeutics, Inc., Kharkiv National Medical University take 42.86% of patent filing during this period.
California, United States
Patent: 4
Massachusetts, United States
Patent: 3
Henan Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
With the analysis among related 21 patents in last 5 years, we discover 5 new entrants. Spero Therapeutics, Inc., Kaifeng Dasong Pharmaceutical Co., Ltd., China Pharmaceutical University are the most active new entrants in this area.
Massachusetts, United States
Patent: 3
Henan Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
With the analysis among 60 patents, we discovered top 6 universities and scientific research institutions by total patent application. University of Melbourne, Kharkiv National Medical University, Ternopil National Economic University are dominant in this area. They take 33.33% of the total patent filing.
Victoria, Australia
Patent: 9
Jiangsu Sheng, China
Patent: 1
Sichuan Sheng, China
Patent: 1